feed,title,long_url,short_url
SeekingAlpha,Zai Lab's Zejula OK'd in China for first-line ovarian cancer,https://seekingalpha.com/news/3612852,
SeekingAlpha,Advaxis EPS beats by $0.06,https://seekingalpha.com/news/3612851,
SeekingAlpha,J&J files U.S. application for expanded use of Darzalex Faspro,https://seekingalpha.com/news/3612850,
SeekingAlpha,Zai Lab's Zeluja OK'd in China for first-line maintenance treatment of ovarian cancer,https://seekingalpha.com/news/3612849,
